Runx2 induces acute myeloid leukemia in cooperation with Cbfβ-SMMHC in mice
- 2 April 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (14), 3323-3332
- https://doi.org/10.1182/blood-2008-06-162248
Abstract
The core-binding factor (CBF) is a master regulator of developmental and differentiation programs, and CBF alterations are frequently associated with acute leukemia. The role of the CBF member RUNX2 in hematopoiesis is poorly understood. Genetic evidence suggests that deregulation of Runx2 may cause myeloid leukemia in mice expressing the fusion oncogene Cbfb-MYH11. In this study, we show that sustained expression of Runx2 modulates Cbfβ-smooth muscle myosin heavy chain (SMMHC)–mediated myeloid leukemia development. Expression of Runx2 is high in the hematopoietic stem cell compartment and decreases during myeloid differentiation. Sustained Runx2 expression hinders myeloid progenitor differentiation capacity and represses expression of CBF targets Csf1R, Mpo, Cebpd, the cell cycle inhibitor Cdkn1a, and myeloid markers Cebpa and Gfi1. In addition, full-length Runx2 cooperates with Cbfβ-SMMHC in leukemia development in transplantation assays. Furthermore, we show that the nuclear matrix–targeting signal and DNA-binding runt-homology domain of Runx2 are essential for its leukemogenic activity. Conversely, Runx2 haplo-insufficiency delays the onset and reduces the incidence of acute myeloid leukemia. Together, these results indicate that Runx2 is expressed in the stem cell compartment, interferes with differentiation and represses CBF targets in the myeloid compartment, and modulates the leukemogenic function of Cbfβ-SMMHC in mouse leukemia.Keywords
This publication has 62 references indexed in Scilit:
- Histone Deacetylase 7 Associates With Runx2 and Represses Its Activity During Osteoblast Maturation in a Deacetylation-Independent MannerJournal of Bone and Mineral Research, 2008
- Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potentialProceedings of the National Academy of Sciences of the United States of America, 2007
- Retroviral Insertional Mutagenesis Identifies Genes that Collaborate with NUP98-HOXD13 during Leukemic TransformationCancer Research, 2007
- Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2Proceedings of the National Academy of Sciences of the United States of America, 2007
- The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETOBlood, 2007
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 miceOncogene, 2005
- Increased Dosage of the RUNX1/AML1 Gene: A Third Mode of RUNX Leukemia?Critical Reviews™ in Eukaryotic Gene Expression, 2005
- Inducible Gene Targeting in MiceScience, 1995
- The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotypeImmunity, 1994